Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Combination Chemotherapy in Treating Patients Who Have Extensive-Stage Small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial update evaluating combination chemotherapy for extensive-stage small cell lung cancer; the current status of the tria…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating VX-710 in combination with doxorubicin and vincristine for recurrent small cell lung cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2013-08-27Clinical Trial Update: Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC) [NA]
The trial investigating hypoxia-guided radiotherapy with cisplatin and etoposide for stage I-III small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults [Phase 3]
Phase 3 trial evaluating an investigational drug plus chemotherapy in chemotherapy-naive small cell lung cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating temozolomide in patients with relapsed or progressive small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial (S0124) comparing cisplatin plus irinotecan versus cisplatin plus etoposide for extensive-stage small cell lung cancer has c…
-
FDA approval · 2013-06-26FDA Approved: TOPOTECAN HYDROCHLORIDE — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare's original application for a generic topotecan hydrochloride product.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) [Phase 2]
Phase 2 trial evaluating irinotecan/cisplatin plus simvastatin in extensive-disease small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating sunitinib as second-line therapy for recurrent small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy [Phase 2]
A Phase 2 clinical trial evaluating a cancer vaccine in combination with the QS-21 adjuvant for small cell lung cancer that has responded to…
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: A Clinical Study of Liposomal Doxorubicin Combined With Ifosfamide Second-line Treatment in Small Cell Lung Cancer [Phase 2]
This document provides an update on a Phase 2 clinical study evaluating liposomal doxorubicin in combination with ifosfamide as second-line …
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors [Phase 1]
Phase 1 trial evaluating the safety and preliminary activity of combining interleukin-12, paclitaxel, and trastuzumab in patients with vario…
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer [Phase 1]
Phase 1 trial of BMS-833923 with carboplatin and etoposide followed by BMS-833923 alone in extensive-stage small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer [Phase 3]
Phase 3 trial comparing early versus late concurrent chemoradiation for limited-stage small-cell lung cancer completed.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer [Phase 1]
This clinical trial update describes a Phase 1 study of the combination of paclitaxel and everolimus for relapsed or refractory small cell l…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 study of irinotecan plus carboplatin for newly diagnosed extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer [Phase 1]
This Phase 1 trial updates the use of a combination of amrubicin and irinotecan for patients with recurrent or relapsed extensive-stage smal…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC [Phase 1, Phase 2]
This clinical trial update reports a Phase 1/2 study of oral vorinostat in combination with topotecan for chemosensitive recurrent small cel…
-
CLINICAL_TRIALS trial_result · 2013-05-16Clinical Trial Update: Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 trial update evaluating amifostine with chemotherapy and radiation in patients with limited-stage small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2013-05-08Clinical Trial Update: A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) [Phase 2]
A Phase 2 randomized study evaluating two enoxaparin sodium doses in combination with standard chemotherapy for stage small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating radiolabeled SMT-487 (Yttrium-90-DOTA-Tyr3-octreotide) in patients with refractory small cell lung cancer or metast…
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer [Phase 2]
Phase 2 study results for dasatinib in relapsed small cell lung cancer are reported (includes extensive stage, limited stage, and recurrent …
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer [Phase 3]
A completed Phase 3 trial comparing Active Symptom Control alone versus with oral topotecan in patients with relapsed resistant small cell l…
-
CLINICAL_TRIALS trial_result · 2013-04-12Clinical Trial Update: Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating a combination chemotherapy regimen for small cell lu…
-
CLINICAL_TRIALS trial_result · 2013-04-10Clinical Trial Update: Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating Paclitaxel, Carboplatin, and DMXAA in extensive-stage small cell lung cancer; the trial has completed.